TYMS and hepatocellular carcinoma: Indeed, TS was the first chemotherapeutic agent evaluated for efficacy against HCC.[6] 5-FU inhibits TS, the sole de novo source of thymidine in cells, thereby shutting down DNA synthesis and inducing cell death.